In this Insight Guide, IQVIA's Jennifer N. Hill and Samuel Foster explore situations stakeholders may face post-launch where Implementation Science can make a difference. Learn how it can be applied in these cases and revisit key activities that are ideally completed before launch, but continue to be valuable if conducted after. https://bit.ly/4olQ97k
About us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
Get directions
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
It was a pleasure connecting with so many of you at #DIA2026. Discover the resources and insights from our conversations at the event here: https://lnkd.in/edCbCzAP
Signing off from #DIA2026. To everyone who made time to meet, joined a session or stopped for a conversation at the booth, thank you. You made this week a meaningful one for our team.
-
-
At IQVIA, the CRA role is evolving to become more strategic through three unique career paths. Which one is right for you? Read the blog to find out: https://bit.ly/4aNLIN2 #WeAreIQVIA
-
-
Consulting roles like Jaskirat's offer so many ways to grow your career. Learn more about consulting at IQVIA: https://bit.ly/4vPWPxc #WeAreIQVIA
-
-
What could the EU Biotech Act mean for the future of innovation in Europe? This blog outlines the proposed incentives and what they signal for investment, development timelines, and competitiveness, helping stakeholders understand how the policy could shape the next phase of biotech growth. Read the blog to explore the implications. https://bit.ly/43w4l4m
-
-
FDA’s Rare Disease Evidence Principles (RDEP) build on existing guidance to provide greater clarity for ultra-rare drug development. For sponsors working in small populations where randomized trials are often not feasible, RDEP outlines clearer evidentiary expectations, reinforcing the role of innovative study designs and high-quality real-world evidence (RWE) in regulatory decision-making. Learn more: https://bit.ly/4fGwJbh
-
Our latest report brings together candid input from 25 leaders across the science-to-patient value chain on how to apply AI responsibly to accelerate progress from discovery to real-world impact. Co-developed with Wiley, it highlights where AI is helping move faster and where barriers still remain. Read it here: https://bit.ly/4aoDafJ
-
-
Featuring insights from the European Congress on Obesity 2026 by Olivia Meadowcroft, this blog examines how definitions of success in obesity management are changing. It outlines emerging priorities around sustained outcomes, personalised care, and broader measures of health to inform future approaches. https://bit.ly/4fOqFNP
-
-
Where could a career at IQVIA take you? Explore our blog for employee journeys, hiring tips and inspiration: https://bit.ly/4utzr7L #WeAreIQVIA
-
-
Nothing beats a job that brings hope to patients around the world. Just ask Gina, who supports clinical trials at IQVIA for rare diseases in pediatric patients. Inspired by her story? Join us: https://bit.ly/4x9i2Ue #WeAreIQVIA